Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1378496rdf:typepubmed:Citationlld:pubmed
pubmed-article:1378496lifeskim:mentionsumls-concept:C0003873lld:lifeskim
pubmed-article:1378496lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:1378496lifeskim:mentionsumls-concept:C0021756lld:lifeskim
pubmed-article:1378496lifeskim:mentionsumls-concept:C0039097lld:lifeskim
pubmed-article:1378496lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:1378496lifeskim:mentionsumls-concept:C0020861lld:lifeskim
pubmed-article:1378496lifeskim:mentionsumls-concept:C0035448lld:lifeskim
pubmed-article:1378496lifeskim:mentionsumls-concept:C0175727lld:lifeskim
pubmed-article:1378496lifeskim:mentionsumls-concept:C0205296lld:lifeskim
pubmed-article:1378496pubmed:issue2lld:pubmed
pubmed-article:1378496pubmed:dateCreated1992-8-20lld:pubmed
pubmed-article:1378496pubmed:abstractTextWe show that rheumatoid arthritis (RA) serum or synovial fluid (SF) increases the growth capacity of normal, interleukin 2 (IL-2) driven cell preparations, compared to normal human serum (NHS). Proliferation in RA serum and SF cultures was primarily associated with expansion of natural killer (NK)-like cells (CD16+, CD57+), and in NHS cultures, with T cell (CD3+ CD4+ CD8+) growth. The capacity of RA serum to promote NK cell growth was related to patient global clinical activity and rheumatoid factor (RF) titers. The NK-like cells, but not the T-like cells, induced high levels of IgM RF synthesis in autologous B cells. Thus, alteration in NK cell growth may disrupt NK-B cell circuits in RA and contribute to B cell dysfunction (RF synthesis).lld:pubmed
pubmed-article:1378496pubmed:languageenglld:pubmed
pubmed-article:1378496pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1378496pubmed:citationSubsetIMlld:pubmed
pubmed-article:1378496pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1378496pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1378496pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1378496pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1378496pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1378496pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1378496pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1378496pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1378496pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1378496pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1378496pubmed:statusMEDLINElld:pubmed
pubmed-article:1378496pubmed:monthFeblld:pubmed
pubmed-article:1378496pubmed:issn0315-162Xlld:pubmed
pubmed-article:1378496pubmed:authorpubmed-author:KayCClld:pubmed
pubmed-article:1378496pubmed:authorpubmed-author:Santiago-Schw...lld:pubmed
pubmed-article:1378496pubmed:authorpubmed-author:CarsonsS ESElld:pubmed
pubmed-article:1378496pubmed:authorpubmed-author:Panagiotopoul...lld:pubmed
pubmed-article:1378496pubmed:issnTypePrintlld:pubmed
pubmed-article:1378496pubmed:volume19lld:pubmed
pubmed-article:1378496pubmed:ownerNLMlld:pubmed
pubmed-article:1378496pubmed:authorsCompleteYlld:pubmed
pubmed-article:1378496pubmed:pagination223-8lld:pubmed
pubmed-article:1378496pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:meshHeadingpubmed-meshheading:1378496-...lld:pubmed
pubmed-article:1378496pubmed:year1992lld:pubmed
pubmed-article:1378496pubmed:articleTitleRheumatoid arthritis serum or synovial fluid and interleukin 2 abnormally expand natural killer-like cells that are potent stimulators of IgM rheumatoid factor.lld:pubmed
pubmed-article:1378496pubmed:affiliationDivision of Rheumatology, Winthrop-University Hospital, Mineola, NY 11501.lld:pubmed
pubmed-article:1378496pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1378496pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1378496lld:pubmed